<!DOCTYPE html>
<html lang="pt" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>NewCo Pharma Trading - Investment Memorandum</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <!-- Chosen Palette: Warm Neutral with Professional Blue Accent -->
    <!-- Application Structure Plan: A single-page, top-down narrative dashboard. The structure guides an investor logically from the high-level problem and opportunity to the specific solution, go-to-market strategy, detailed financials, and the team. This dashboard format was chosen over a simple document structure to make dense financial data easily digestible and interactive. Key interactions include dynamic charts for financial projections and a sensitivity calculator for working capital, allowing investors to immediately grasp the impact of operational efficiencies. The flow is designed for persuasion and clarity, answering core investor questions at each stage. -->
    <!-- Visualization & Content Choices: 
        - Market Problem: Goal: Inform/Impact -> Method: Large stat cards (HTML/CSS) -> Interaction: None -> Justification: Key metrics like '100% of countries affected' are more impactful as bold statements than chart points.
        - Financial Projections (P&L): Goal: Show Change/Growth -> Method: Combo Bar/Line Chart (Chart.js) -> Interaction: Hover tooltips -> Justification: Clearly displays revenue growth (bars) against EBITDA profitability (line) over time.
        - Revenue by Market: Goal: Compare/Organize -> Method: Stacked Bar Chart (Chart.js) -> Interaction: Hover tooltips -> Justification: Shows the phased market entry strategy and diversification of revenue streams over 5 years.
        - OPEX Breakdown: Goal: Inform/Proportion -> Method: Donut Chart (Chart.js) -> Interaction: Hover tooltips -> Justification: Provides a quick, clear view of the main cost drivers in the first year.
        - WC Sensitivity: Goal: Explore/Engage -> Method: HTML Sliders + JS -> Interaction: User-controlled sliders updating a key metric -> Justification: The most critical interaction. It directly addresses a key financial risk (cash trough) and demonstrates the team's understanding of operational levers, building investor confidence. It uses data from the sensitivity analysis.
        - Asset-light Model: Goal: Explain/Organize -> Method: Diagram using HTML/CSS (Flexbox) -> Interaction: None -> Justification: A simple visual flow is sufficient to explain the business model without needing complex libraries. -->
    <!-- CONFIRMATION: NO SVG graphics used. NO Mermaid JS used. -->
    <style>
        body {
            font-family: 'Inter', sans-serif;
            background-color: #FDFBF8;
            color: #1a202c;
        }
        .chart-container {
            position: relative;
            width: 100%;
            max-width: 800px;
            margin-left: auto;
            margin-right: auto;
            height: 400px;
            max-height: 50vh;
        }
        .nav-link {
            transition: all 0.3s ease;
            border-bottom: 2px solid transparent;
        }
        .nav-link.active {
            color: #2563eb;
            border-bottom-color: #2563eb;
        }
        .stat-card {
            background-color: #FFFFFF;
            border: 1px solid #E2E8F0;
            border-radius: 0.75rem;
            padding: 1.5rem;
            text-align: center;
            box-shadow: 0 4px 6px -1px rgb(0 0 0 / 0.1), 0 2px 4px -2px rgb(0 0 0 / 0.1);
        }
        .pill-button {
            transition: all 0.2s ease-in-out;
        }
        .pill-button.active {
            background-color: #2563eb;
            color: #ffffff;
        }
        /* Styles from subpage */
        .card {
            background-color: #FFFFFF;
            border: 1px solid #F0EBE5;
            border-radius: 0.75rem;
            box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.05), 0 2px 4px -2px rgba(0, 0, 0, 0.05);
            transition: all 0.3s ease;
        }
        .card:hover {
            transform: translateY(-4px);
            box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.07), 0 4px 6px -4px rgba(0, 0, 0, 0.07);
        }
        .sub-chart-container {
            position: relative;
            width: 100%;
            max-width: 400px;
            margin-left: auto;
            margin-right: auto;
            height: 300px;
            max-height: 400px;
        }
        @media (min-width: 768px) {
            .sub-chart-container {
                height: 350px;
            }
        }
        .btn-primary {
            background-color: #D68A7B;
            color: white;
            transition: background-color 0.3s ease;
        }
        .btn-primary:hover {
            background-color: #C06C5B;
        }
        .pill-diagram-item {
            background-color: #F0EBE5;
            border: 1px solid #E4DCD3;
            transition: all 0.3s ease;
        }
        .pill-diagram-item:hover {
            background-color: #E4DCD3;
            transform: scale(1.05);
        }
        .flow-step {
            cursor: pointer;
            transition: all 0.3s ease;
            border: 2px solid #E4DCD3;
        }
        .flow-step.active, .flow-step:hover {
            background-color: #F0EBE5;
            border-color: #D68A7B;
        }
    </style>
</head>
<body class="antialiased">

    <header class="sticky top-0 bg-white/80 backdrop-blur-lg z-50 shadow-sm">
        <nav class="container mx-auto px-4 sm:px-6 lg:px-8">
            <div class="flex items-center justify-between h-16">
                <div class="flex items-center">
                    <span class="font-bold text-xl text-gray-800">NewCo Pharma Trading</span>
                </div>
                <div class="hidden md:block">
                    <div class="ml-10 flex items-baseline space-x-4">
                        <a href="#opportunity" class="nav-link px-3 py-2 rounded-md text-sm font-medium text-gray-700 hover:text-blue-600">Oportunidade</a>
                        <a href="#solution" class="nav-link px-3 py-2 rounded-md text-sm font-medium text-gray-700 hover:text-blue-600">Solu√ß√£o</a>
                        <a href="#strategy" class="nav-link px-3 py-2 rounded-md text-sm font-medium text-gray-700 hover:text-blue-600">Estrat√©gia</a>
                        <a href="#financials" class="nav-link px-3 py-2 rounded-md text-sm font-medium text-gray-700 hover:text-blue-600">Finan√ßas</a>
                        <a href="#ask" class="nav-link px-3 py-2 rounded-md text-sm font-medium text-gray-700 hover:text-blue-600">O Pedido</a>
                        <a href="#cma-annex" class="nav-link px-3 py-2 rounded-md text-sm font-medium text-gray-700 hover:text-blue-600">Anexo: CMA</a>
                    </div>
                </div>
            </div>
        </nav>
    </header>

    <main class="container mx-auto px-4 sm:px-6 lg:px-8 py-8 md:py-12">

        <section class="text-center mb-16">
            <h1 class="text-4xl md:text-5xl font-bold text-gray-900 leading-tight">Memorando de Investimento: NewCo Pharma Trading</h1>
            <p class="mt-4 text-lg text-gray-600 max-w-3xl mx-auto">Uma oportunidade de investimento Pre-Seed para resolver a crise sist√©mica de escassez de medicamentos na Europa.</p>
            <div class="mt-8 grid grid-cols-1 md:grid-cols-3 gap-6 max-w-4xl mx-auto">
                <div class="stat-card">
                    <span class="text-3xl font-bold text-blue-600">‚Ç¨350k - ‚Ç¨450k</span>
                    <p class="text-sm text-gray-500 mt-1">Pedido Pre-Seed</p>
                </div>
                <div class="stat-card">
                    <span class="text-3xl font-bold text-blue-600">‚Ç¨90 Mil Milh√µes</span>
                    <p class="text-sm text-gray-500 mt-1">Mercado Europeu de Log√≠stica Farmac√™utica</p>
                </div>
                <div class="stat-card">
                    <span class="text-3xl font-bold text-blue-600">Ano 2</span>
                    <p class="text-sm text-gray-500 mt-1">Proje√ß√£o de EBITDA Positivo</p>
                </div>
            </div>
        </section>

        <section id="opportunity" class="scroll-mt-20 mb-16">
            <h2 class="text-3xl font-bold text-center mb-2 text-gray-900">A Oportunidade: A Crise de Medicamentos na Europa</h2>
            <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">Esta sec√ß√£o detalha a escala e as causas da crise de escassez de medicamentos na Europa. A an√°lise demonstra um problema sist√©mico e crescente que criou uma necessidade urgente de mercado, validada por novas diretrizes regulat√≥rias da UE, como o "Critical Medicines Act".</p>
            
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 text-center mb-12">
                <div class="stat-card">
                    <div class="text-4xl font-bold text-gray-800">100%</div>
                    <p class="text-gray-600">dos pa√≠ses da UE reportaram escassez de medicamentos</p>
                </div>
                <div class="stat-card">
                    <div class="text-4xl font-bold text-gray-800">~11 horas</div>
                    <p class="text-gray-600">por semana gastas por farmac√™uticos a gerir faltas</p>
                </div>
                <div class="stat-card">
                    <div class="text-4xl font-bold text-gray-800">3x</div>
                    <p class="text-gray-600">Aumento de notifica√ß√µes de falta na Alemanha (2021-2023)</p>
                </div>
            </div>

            <div class="bg-white p-8 rounded-xl shadow-md border border-gray-200">
                <h3 class="text-xl font-bold text-center text-gray-800 mb-6">O Paradoxo do Gen√©rico: Causas da Falha Sist√©mica</h3>
                <div class="flex flex-col md:flex-row items-center justify-around space-y-4 md:space-y-0 md:space-x-4">
                    <div class="text-center">
                        <div class="p-4 bg-blue-100 rounded-lg inline-block">
                            <span class="text-2xl">üìâ</span>
                        </div>
                        <h4 class="font-semibold mt-2">Press√£o de Pre√ßos</h4>
                        <p class="text-sm text-gray-500 max-w-xs">Eros√£o de margens em medicamentos gen√©ricos.</p>
                    </div>
                    <div class="text-2xl text-blue-400 font-mono">‚ñ∂</div>
                    <div class="text-center">
                        <div class="p-4 bg-blue-100 rounded-lg inline-block">
                            <span class="text-2xl">üåè</span>
                        </div>
                        <h4 class="font-semibold mt-2">Vulnerabilidades de Fabrico</h4>
                        <p class="text-sm text-gray-500 max-w-xs">Concentra√ß√£o de APIs na √Åsia.</p>
                    </div>
                    <div class="text-2xl text-blue-400 font-mono">‚ñ∂</div>
                    <div class="text-center">
                         <div class="p-4 bg-blue-100 rounded-lg inline-block">
                            <span class="text-2xl">üì¶</span>
                        </div>
                        <h4 class="font-semibold mt-2">Cadeias "Just-in-Time"</h4>
                        <p class="text-sm text-gray-500 max-w-xs">Falta de buffers para absorver choques.</p>
                    </div>
                </div>
            </div>
        </section>

        <section id="solution" class="scroll-mt-20 mb-16">
            <h2 class="text-3xl font-bold text-center mb-2 text-gray-900">A Solu√ß√£o: NewCo Pharma Trading</h2>
            <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">A NewCo foi concebida para capitalizar esta oportunidade atrav√©s de um modelo de neg√≥cio √°gil e focado na tecnologia. Em vez de competir com os grandes distribuidores, focamo-nos em arbitrar a disponibilidade de medicamentos cr√≠ticos, criando valor onde a cadeia de abastecimento tradicional falha.</p>
            <div class="bg-white p-8 rounded-xl shadow-md border border-gray-200">
                <h3 class="text-xl font-bold text-center text-gray-800 mb-6">Modelo de Neg√≥cio "Asset-Light"</h3>
                <div class="grid grid-cols-1 md:grid-cols-3 gap-8 text-center">
                    <div>
                        <div class="p-4 bg-green-100 rounded-lg inline-block mb-3">
                            <span class="text-3xl">üìú</span>
                        </div>
                        <h4 class="font-semibold text-lg">Autoriza√ß√£o Pr√≥pria (WDA)</h4>
                        <p class="text-gray-600">Controlo regulat√≥rio total sobre as opera√ß√µes sem o peso de ativos f√≠sicos.</p>
                    </div>
                    <div>
                        <div class="p-4 bg-green-100 rounded-lg inline-block mb-3">
                            <span class="text-3xl">üåê</span>
                        </div>
                        <h4 class="font-semibold text-lg">Rede 3PL Certificada</h4>
                        <p class="text-gray-600">Escalabilidade e flexibilidade log√≠stica sem investimento de capital em armaz√©ns ou frotas.</p>
                    </div>
                    <div>
                        <div class="p-4 bg-green-100 rounded-lg inline-block mb-3">
                            <span class="text-3xl">ü§ñ</span>
                        </div>
                        <h4 class="font-semibold text-lg">Tecnologia e Automa√ß√£o</h4>
                        <p class="text-gray-600">Integra√ß√£o desde o Dia 1 (QMS, CRM, NMVS) para efici√™ncia e conformidade.</p>
                    </div>
                </div>
                <div class="mt-8 text-center">
                    <p class="text-gray-700 font-medium">A nossa proposta de valor √© clara: garantir o acesso a medicamentos cr√≠ticos, reduzir o fardo administrativo para hospitais e autoridades de sa√∫de, e assegurar a conformidade regulat√≥ria.</p>
                </div>
            </div>
        </section>

        <section id="strategy" class="scroll-mt-20 mb-16">
            <h2 class="text-3xl font-bold text-center mb-2 text-gray-900">Estrat√©gia Go-to-Market e Vantagem Competitiva</h2>
            <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">A nossa estrat√©gia comercial √© multifacetada, come√ßando com uma entrada faseada em mercados-alvo onde j√° possu√≠mos conhecimento profundo. A nossa vantagem competitiva n√£o reside apenas no nosso modelo, mas na nossa integra√ß√£o sist√©mica comprovada e nas parcerias estrat√©gicas j√° estabelecidas.</p>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-8">
                <div class="bg-white p-6 rounded-xl shadow-md border border-gray-200">
                    <h3 class="font-bold text-lg mb-4">1. Entrada Faseada no Mercado</h3>
                    <p class="text-gray-600 mb-4">Foco inicial em quatro mercados estrat√©gicos com rotas regulat√≥rias claras:</p>
                    <ul class="space-y-2">
                        <li class="flex items-center"><span class="font-mono text-blue-600 mr-2">üáµüáπ</span> Portugal: Processo INFARMED</li>
                        <li class="flex items-center"><span class="font-mono text-blue-600 mr-2">üá™üá∏</span> Espanha: Importa√ß√£o excecional</li>
                        <li class="flex items-center"><span class="font-mono text-blue-600 mr-2">üá≤üáπ</span> Malta: Ponto de entrada estrat√©gico na UE</li>
                        <li class="flex items-center"><span class="font-mono text-blue-600 mr-2">üá¨üá∑</span> Gr√©cia: Mercado com elevada procura</li>
                    </ul>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-md border border-gray-200">
                    <h3 class="font-bold text-lg mb-4">2. O Nosso "Moat": Integra√ß√£o Sist√©mica</h3>
                    <p class="text-gray-600 mb-4">A nossa an√°lise de portf√≥lio de clientes demonstra uma profunda integra√ß√£o nos sistemas de sa√∫de p√∫blicos Ib√©ricos. Esta n√£o √© uma rela√ß√£o transacional; √© uma parceria estrat√©gica que constitui uma barreira √† entrada significativa.</p>
                    <p class="text-gray-600 font-semibold">Parceiros Estrat√©gicos Tier 1 (e.g., GPW Group, BELDIMED) validam o nosso modelo de duplo canal e fornecem um caminho para uma r√°pida expans√£o internacional.</p>
                </div>
            </div>
        </section>

        <section id="financials" class="scroll-mt-20 mb-16">
            <h2 class="text-3xl font-bold text-center mb-2 text-gray-900">Proje√ß√µes Financeiras</h2>
             <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">As nossas proje√ß√µes financeiras para 5 anos s√£o baseadas num modelo conservador, demonstrando um caminho claro para a rentabilidade e um crescimento sustent√°vel. Esta sec√ß√£o oferece uma vis√£o interativa dos nossos principais indicadores financeiros, receitas por mercado, e sensibilidade do capital de giro.</p>
            
            <div class="bg-white p-6 rounded-xl shadow-lg border border-gray-200 mb-8">
                <h3 class="text-xl font-bold text-center mb-4">Resumo P&L: Receita e Rentabilidade (5 Anos)</h3>
                <div class="chart-container">
                    <canvas id="pnlChart"></canvas>
                </div>
            </div>

            <div class="grid grid-cols-1 lg:grid-cols-2 gap-8 mb-8">
                <div class="bg-white p-6 rounded-xl shadow-lg border border-gray-200">
                    <h3 class="text-xl font-bold text-center mb-4">Crescimento da Receita por Mercado</h3>
                     <div class="chart-container" style="height: 380px;">
                        <canvas id="revenueByLaneChart"></canvas>
                    </div>
                </div>
                <div class="bg-white p-6 rounded-xl shadow-lg border border-gray-200">
                     <h3 class="text-xl font-bold text-center mb-4">An√°lise OPEX (Ano 1)</h3>
                     <div class="chart-container" style="height: 380px;">
                        <canvas id="opexChart"></canvas>
                    </div>
                </div>
            </div>

            <div class="bg-white p-8 rounded-xl shadow-lg border border-gray-200">
                <h3 class="text-xl font-bold text-center mb-2">An√°lise de Sensibilidade do Capital de Giro</h3>
                <p class="text-center text-gray-600 max-w-2xl mx-auto mb-6">O nosso maior desafio de fluxo de caixa √© o "cash trough". Este simulador interativo demonstra como a otimiza√ß√£o dos prazos de pagamento (DPO) e recebimento (DSO) pode reduzir drasticamente a nossa necessidade m√°xima de caixa.</p>
                <div class="grid grid-cols-1 md:grid-cols-2 gap-6 items-center">
                    <div>
                        <div class="mb-4">
                            <label for="dsoSlider" class="block mb-1 font-medium text-gray-700">Prazo M√©dio de Recebimento (DSO): <span id="dsoValue" class="font-bold text-blue-600">60</span> dias</label>
                            <input id="dsoSlider" type="range" min="45" max="60" value="60" step="15" class="w-full h-2 bg-gray-200 rounded-lg appearance-none cursor-pointer">
                        </div>
                        <div>
                            <label for="dpoSlider" class="block mb-1 font-medium text-gray-700">Prazo M√©dio de Pagamento (DPO): <span id="dpoValue" class="font-bold text-blue-600">8</span> dias</label>
                            <input id="dpoSlider" type="range" min="8" max="30" value="8" step="22" class="w-full h-2 bg-gray-200 rounded-lg appearance-none cursor-pointer">
                        </div>
                    </div>
                    <div class="text-center bg-blue-50 p-6 rounded-lg">
                        <p class="text-gray-600 text-lg">Necessidade M√°xima de Caixa (Cash Trough)</p>
                        <div id="cashTroughResult" class="text-4xl font-bold text-blue-700 mt-2">-‚Ç¨205,775</div>
                    </div>
                </div>
            </div>
        </section>
        
        <section id="ask" class="scroll-mt-20 mb-16">
            <h2 class="text-3xl font-bold text-center mb-2 text-gray-900">O Pedido e Uso dos Fundos</h2>
            <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">Procuramos um investimento pre-seed para financiar 18 meses de opera√ß√µes, permitindo-nos alcan√ßar marcos cruciais e preparar a empresa para uma ronda seed com uma base s√≥lida de execu√ß√£o e dados de mercado.</p>
             <div class="max-w-4xl mx-auto grid grid-cols-1 md:grid-cols-2 gap-8">
                <div class="bg-white p-8 rounded-xl shadow-md border border-gray-200">
                    <h3 class="font-bold text-2xl mb-4 text-center">Pedido de Investimento</h3>
                    <div class="text-center">
                        <p class="text-5xl font-bold text-blue-600">‚Ç¨350k - ‚Ç¨450k</p>
                        <p class="text-gray-500 mt-2">Ronda Pre-Seed</p>
                    </div>
                </div>
                 <div class="bg-white p-8 rounded-xl shadow-md border border-gray-200">
                    <h3 class="font-bold text-xl mb-4">Utiliza√ß√£o dos Fundos</h3>
                    <ul class="space-y-3 text-gray-700">
                        <li class="flex items-start">
                            <span class="text-green-500 mr-2">‚úì</span>
                            <div><span class="font-semibold">18 Meses de OPEX:</span> Cobrir sal√°rios, custos fixos e despesas operacionais.</div>
                        </li>
                        <li class="flex items-start">
                            <span class="text-green-500 mr-2">‚úì</span>
                            <div><span class="font-semibold">Capital de Giro:</span> Financiar o "cash trough" e garantir a liquidez das opera√ß√µes.</div>
                        </li>
                        <li class="flex items-start">
                            <span class="text-green-500 mr-2">‚úì</span>
                            <div><span class="font-semibold">Stack Tecnol√≥gico:</span> Acelerar o desenvolvimento da nossa plataforma de automa√ß√£o.</div>
                        </li>
                    </ul>
                </div>
            </div>
             <div class="mt-8 bg-blue-600 text-white p-6 rounded-xl text-center max-w-4xl mx-auto">
                <h4 class="font-bold text-xl">Marco Principal</h4>
                <p>Atingir o break-even de EBITDA em 18 meses.</p>
            </div>
        </section>

        <hr class="my-16 border-gray-300"/>

        <!-- Start of Annex Content -->
        <section id="cma-annex" class="scroll-mt-20">
            <div class="text-center mb-12">
                <h2 class="text-4xl font-bold mb-4 text-gray-900">Anexo: Oportunidades no "EU Critical Medicines Act"</h2>
                <p class="text-lg text-gray-600 max-w-3xl mx-auto">Esta legisla√ß√£o hist√≥rica reformula a cadeia de abastecimento farmac√™utica da UE, criando oportunidades de neg√≥cio diretas e baseadas em dados que validam o timing e a necessidade do modelo de neg√≥cio da NewCo.</p>
            </div>

            <div class="card p-8 mb-12">
                <h3 class="text-2xl font-semibold text-center mb-6 text-gray-800">Pilares Centrais do Ato</h3>
                <p class="text-center text-gray-500 mb-8">A legisla√ß√£o baseia-se em tr√™s objetivos fundamentais. Compreender estes pilares √© a chave para identificar onde novos servi√ßos e solu√ß√µes ser√£o mais valorizados. Passe o rato sobre cada pilar para saber mais.</p>
                <div class="grid md:grid-cols-3 gap-6 text-center">
                    <div class="pill-diagram-item p-6 rounded-lg relative group">
                        <div class="text-3xl mb-3">üõ°Ô∏è</div>
                        <h4 class="font-bold text-lg">Refor√ßar a Seguran√ßa do Abastecimento</h4>
                        <div class="absolute bottom-full mb-2 w-60 left-1/2 -translate-x-1/2 bg-gray-800 text-white text-sm rounded-lg p-3 opacity-0 group-hover:opacity-100 transition-opacity duration-300 pointer-events-none">
                            <strong>Oportunidade:</strong> Oferecer diversifica√ß√£o da cadeia de abastecimento, avalia√ß√£o de riscos e solu√ß√µes de fabrico ou armazenamento baseadas na UE.
                        </div>
                    </div>
                    <div class="pill-diagram-item p-6 rounded-lg relative group">
                        <div class="text-3xl mb-3">üíä</div>
                        <h4 class="font-bold text-lg">Promover a Disponibilidade</h4>
                        <div class="absolute bottom-full mb-2 w-60 left-1/2 -translate-x-1/2 bg-gray-800 text-white text-sm rounded-lg p-3 opacity-0 group-hover:opacity-100 transition-opacity duration-300 pointer-events-none">
                            <strong>Oportunidade:</strong> Desenvolver log√≠stica de armazenamento estrat√©gico, an√°lise preditiva de escassez e redes de distribui√ß√£o r√°pida.
                        </div>
                    </div>
                    <div class="pill-diagram-item p-6 rounded-lg relative group">
                        <div class="text-3xl mb-3">üí∂</div>
                        <h4 class="font-bold text-lg">Garantir a Acessibilidade</h4>
                        <div class="absolute bottom-full mb-2 w-60 left-1/2 -translate-x-1/2 bg-gray-800 text-white text-sm rounded-lg p-3 opacity-0 group-hover:opacity-100 transition-opacity duration-300 pointer-events-none">
                            <strong>Oportunidade:</strong> Atuar como agente de compras para concursos p√∫blicos conjuntos da UE, focando-se em gen√©ricos e biossimilares de alto volume.
                        </div>
                    </div>
                </div>
            </div>
        
            <div class="mt-16 scroll-mt-20">
                <h2 class="text-3xl font-bold text-center mb-2 text-gray-800">Oportunidade 1: Diversifica√ß√£o da Cadeia de Abastecimento</h2>
                <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">O Ato ir√° obrigar os Titulares de Autoriza√ß√£o de Introdu√ß√£o no Mercado (AIM) a reduzir a depend√™ncia de fornecedores √∫nicos, especialmente fora da UE. Isto cria um mercado para servi√ßos que mapeiam, avaliam e reconstroem cadeias de abastecimento mais resilientes.</p>
                <div class="card grid md:grid-cols-2 gap-8 items-center p-8">
                    <div>
                        <h3 class="text-xl font-semibold mb-3 text-gray-800">O Desafio: Risco de Concentra√ß√£o Geopol√≠tica</h3>
                        <p class="text-gray-600 mb-4">Atualmente, a UE √© altamente dependente de alguns pa√≠ses para Ingredientes Farmac√™uticos Ativos (APIs). Dados da Comiss√£o Europeia sugerem que mais de 60% de certos APIs essenciais prov√™m da China e da √çndia, criando uma vulnerabilidade significativa.</p>
                        <h4 class="font-semibold mt-6 mb-2 text-gray-800">Servi√ßos Acion√°veis para Distribuidores:</h4>
                        <ul class="list-disc list-inside text-gray-600 space-y-2">
                            <li><strong>Auditoria e Vetting de Fornecedores:</strong> Identificar e qualificar fornecedores alternativos de APIs e produtos acabados em novas regi√µes (ex: Europa de Leste, Am√©rica Latina).</li>
                            <li><strong>Log√≠stica-como-Servi√ßo:</strong> Fornecer solu√ß√µes log√≠sticas multi-origem que ofere√ßam flexibilidade e redund√¢ncia aos AIMs.</li>
                            <li><strong>Consultoria:</strong> Ajudar as PMEs a criar os planos obrigat√≥rios de mitiga√ß√£o de risco da cadeia de abastecimento exigidos pela nova legisla√ß√£o.</li>
                        </ul>
                    </div>
                    <div>
                        <div class="sub-chart-container">
                            <canvas id="apiSourceChart"></canvas>
                        </div>
                        <div class="text-center mt-4">
                            <button id="toggleApiSourceBtn" class="btn-primary font-semibold py-2 px-4 rounded-lg">Mostrar Cen√°rio Alvo P√≥s-Ato</button>
                        </div>
                    </div>
                </div>
            </div>

            <div class="mt-16 scroll-mt-20">
                <h2 class="text-3xl font-bold text-center mb-2 text-gray-800">Oportunidade 2: Armazenamento Estrat√©gico</h2>
                <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">Para prevenir os efeitos devastadores da escassez, o Ato ir√° promover a manuten√ß√£o de stocks "tamp√£o" de medicamentos cr√≠ticos. Isto vai al√©m do simples armazenamento, exigindo solu√ß√µes log√≠sticas especializadas, conformes e reativas.</p>
                <div class="card grid md:grid-cols-2 gap-8 items-center p-8">
                     <div>
                        <div class="sub-chart-container">
                            <canvas id="shortageCostChart"></canvas>
                        </div>
                    </div>
                    <div>
                        <h3 class="text-xl font-semibold mb-3 text-gray-800">O Alto Custo de uma Rutura de Stock</h3>
                        <p class="text-gray-600 mb-4">A escassez de medicamentos n√£o √© apenas um inconveniente; √© um fardo financeiro massivo para os sistemas de sa√∫de. Um relat√≥rio de 2021 da Associa√ß√£o Europeia de Farmac√™uticos Hospitalares (EAHP) destaca que a escassez for√ßa o uso de alternativas mais caras e aumenta a carga de trabalho administrativo, custando milhares de milh√µes anualmente.</p>
                        <h4 class="font-semibold mt-6 mb-2 text-gray-800">Servi√ßos Acion√°veis para Distribuidores:</h4>
                        <ul class="list-disc list-inside text-gray-600 space-y-2">
                            <li><strong>Armazenamento Conforme com GDP:</strong> Oferecer instala√ß√µes de armazenamento especializadas e com temperatura controlada para stocks estrat√©gicos nacionais ou regionais.</li>
                            <li><strong>Sistemas de Gest√£o de Invent√°rio:</strong> Fornecer plataformas que d√£o √†s autoridades visibilidade em tempo real dos n√≠veis de stock e datas de validade.</li>
                            <li><strong>Log√≠stica de Desloca√ß√£o R√°pida:</strong> Criar planos pr√©-aprovados para distribuir rapidamente medicamentos armazenados para √°reas afetadas durante uma crise.</li>
                        </ul>
                    </div>
                </div>
            </div>

            <div class="mt-16 scroll-mt-20">
                <h2 class="text-3xl font-bold text-center mb-2 text-gray-800">Oportunidade 3: Servi√ßos de Dados e Relat√≥rios</h2>
                <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">A legisla√ß√£o exige uma monitoriza√ß√£o digital melhorada das cadeias de abastecimento e o relat√≥rio atempado de potenciais faltas a uma plataforma central da UE. As empresas, especialmente as PMEs, precisar√£o de apoio para cumprir estes requisitos intensivos em dados.</p>
                <div class="card p-8">
                    <h3 class="text-xl font-semibold mb-3 text-center text-gray-800">O Novo Fluxo de Dados para a Preven√ß√£o de Escassez</h3>
                     <p class="text-center text-gray-500 mb-8">O Ato estabelece uma cadeia de relat√≥rios clara para permitir uma gest√£o proativa da escassez. Este processo cria a necessidade de ferramentas que possam agregar, analisar e transmitir dados de forma transparente. Clique em cada passo para ver a oportunidade associada.</p>
                    <div class="flex flex-col md:flex-row justify-center items-center gap-4 md:gap-0 my-6">
                        <div id="flow-1" class="flow-step w-full md:w-1/4 p-4 rounded-lg text-center">
                            <strong>1. Fabricante / AIM</strong>
                            <p class="text-sm">Monitoriza stock interno e procura</p>
                        </div>
                        <div class="text-2xl text-gray-400 transform rotate-90 md:rotate-0">‚Üí</div>
                        <div id="flow-2" class="flow-step w-full md:w-1/4 p-4 rounded-lg text-center">
                            <strong>2. Autoridade Nacional</strong>
                            <p class="text-sm">Recebe notifica√ß√µes de escassez</p>
                        </div>
                        <div class="text-2xl text-gray-400 transform rotate-90 md:rotate-0">‚Üí</div>
                        <div id="flow-3" class="flow-step w-full md:w-1/4 p-4 rounded-lg text-center">
                            <strong>3. EMA / Plataforma UE</strong>
                            <p class="text-sm">Agrega dados de toda a UE</p>
                        </div>
                    </div>
                    <div id="flow-details" class="mt-6 p-6 bg-gray-50 rounded-lg min-h-[150px] border border-gray-200">
                        <p class="text-gray-700">Selecione um passo acima para ver os detalhes.</p>
                    </div>
                </div>
            </div>

            <div class="mt-16 scroll-mt-20">
                <h2 class="text-3xl font-bold text-center mb-2 text-gray-800">Oportunidade 4: Sourcing para Contrata√ß√£o P√∫blica Conjunta da UE</h2>
                <p class="text-center text-gray-600 max-w-3xl mx-auto mb-10">O Ato ir√° refor√ßar os mecanismos para que a UE atue como um comprador √∫nico para medicamentos cr√≠ticos, especialmente durante emerg√™ncias de sa√∫de. Traders e distribuidores √°geis podem tornar-se parceiros chave nestes concursos de alto valor.</p>
                <div class="card p-8">
                    <h3 class="text-xl font-semibold mb-4 text-center text-gray-800">A Escala do Mercado Pan-Europeu</h3>
                    <p class="text-center text-gray-500 mb-8">O foco em gen√©ricos e biossimilares para a lista de medicamentos cr√≠ticos da Uni√£o abre um vasto mercado endere√ß√°vel. O sucesso nesta √°rea depende de pre√ßos competitivos, fornecimento fi√°vel e compreens√£o do processo de concurso.</p>
                    <div class="grid md:grid-cols-3 gap-6">
                        <div class="text-center bg-gray-50 p-6 rounded-lg border border-gray-200">
                            <div class="text-4xl font-bold text-[#C06C5B]">‚Ç¨100B+</div>
                            <p class="font-semibold mt-2">Mercado Anual de Gen√©ricos na UE</p>
                            <p class="text-sm text-gray-500 mt-1">(Fonte: Medicines for Europe)</p>
                        </div>
                        <div class="text-center bg-gray-50 p-6 rounded-lg border border-gray-200">
                            <div class="text-4xl font-bold text-[#C06C5B]">~70%</div>
                            <p class="font-semibold mt-2">dos Medicamentos em volume na UE s√£o gen√©ricos</p>
                            <p class="text-sm text-gray-500 mt-1">(Fonte: EFPIA)</p>
                        </div>
                        <div class="text-center bg-gray-50 p-6 rounded-lg border border-gray-200">
                            <div class="text-4xl font-bold text-[#C06C5B]">400+</div>
                            <p class="font-semibold mt-2">Medicamentos na lista preliminar de cr√≠ticos</p>
                            <p class="text-sm text-gray-500 mt-1">(Fonte: Comiss√£o Europeia)</p>
                        </div>
                    </div>
                     <h4 class="font-semibold mt-8 mb-2 text-center text-gray-800">Servi√ßos Acion√°veis para Traders:</h4>
                     <ul class="list-disc list-inside text-gray-600 space-y-2 max-w-xl mx-auto">
                            <li><strong>Intelig√™ncia de Concursos:</strong> Monitorizar e analisar concursos p√∫blicos conjuntos da UE para identificar oportunidades.</li>
                            <li><strong>Rede de Sourcing Global:</strong> Construir uma rede robusta de fabricantes pr√©-qualificados para responder rapidamente a pedidos de fornecimento.</li>
                            <li><strong>Apoio Regulat√≥rio e de Licita√ß√£o:</strong> Oferecer servi√ßos para ajudar os fabricantes a navegar no complexo processo de submiss√£o de propostas da UE.</li>
                        </ul>
                </div>
            </div>
        </section>
        <!-- End of Annex Content -->

    </main>
<script>
document.addEventListener('DOMContentLoaded', function () {
    const financialData = {
        pnl: {
            years: ['Ano 1', 'Ano 2', 'Ano 3', 'Ano 4', 'Ano 5'],
            revenue: [1000000, 1500000, 1800000, 2100000, 2500000],
            grossProfit: [242500, 365357, 442000, 519985, 625000],
            ebitda: [-22100, 84785, 90535, 143231, 231851]
        },
        revenueByLane: {
            years: ['Ano 1', 'Ano 2', 'Ano 3', 'Ano 4', 'Ano 5'],
            pt: [250000, 321429, 400000, 501493, 608108],
            es: [0, 107143, 120000, 156716, 202703],
            mt: [375000, 535714, 640000, 720896, 844595],
            gr: [375000, 535714, 640000, 720896, 844595]
        },
        opexY1: {
            labels: ['Sal√°rios', 'Consultoria QA/Reg', 'Taxas 3PL', 'Seguros', 'IT', 'Viagens/BD', 'Marketing', 'Legal/Cont.'],
            data: [166600, 18000, 12000, 8000, 12000, 24000, 12000, 12000]
        },
        sensitivity: {
            'DSO60_DPO8': -205775,
            'DSO60_DPO30': -137386,
            'DSO45_DPO8': -144131,
            'DSO45_DPO30': -75742
        }
    };

    const formatCurrency = (value) => new Intl.NumberFormat('de-DE', { style: 'currency', currency: 'EUR' }).format(value);

    new Chart(document.getElementById('pnlChart'), {
        type: 'bar',
        data: {
            labels: financialData.pnl.years,
            datasets: [{
                label: 'Receita',
                data: financialData.pnl.revenue,
                backgroundColor: 'rgba(59, 130, 246, 0.5)',
                borderColor: 'rgba(59, 130, 246, 1)',
                borderWidth: 1,
                yAxisID: 'y'
            }, {
                label: 'EBITDA',
                data: financialData.pnl.ebitda,
                backgroundColor: 'rgba(22, 163, 74, 1)',
                borderColor: 'rgba(22, 163, 74, 1)',
                type: 'line',
                yAxisID: 'y',
                tension: 0.3
            }]
        },
        options: {
            responsive: true,
            maintainAspectRatio: false,
            scales: {
                y: {
                    beginAtZero: true,
                    ticks: {
                        callback: value => formatCurrency(value).replace(',00', '')
                    }
                }
            },
            plugins: {
                tooltip: {
                    callbacks: {
                        label: function(context) {
                            let label = context.dataset.label || '';
                            if (label) {
                                label += ': ';
                            }
                            if (context.parsed.y !== null) {
                                label += formatCurrency(context.parsed.y);
                            }
                            return label;
                        }
                    }
                }
            }
        }
    });

    new Chart(document.getElementById('revenueByLaneChart'), {
        type: 'bar',
        data: {
            labels: financialData.revenueByLane.years,
            datasets: [{
                label: 'Portugal',
                data: financialData.revenueByLane.pt,
                backgroundColor: '#3B82F6',
            }, {
                label: 'Espanha',
                data: financialData.revenueByLane.es,
                backgroundColor: '#10B981',
            }, {
                label: 'Malta',
                data: financialData.revenueByLane.mt,
                backgroundColor: '#F97316',
            }, {
                label: 'Gr√©cia',
                data: financialData.revenueByLane.gr,
                backgroundColor: '#8B5CF6',
            }]
        },
        options: {
            responsive: true,
            maintainAspectRatio: false,
            scales: {
                x: { stacked: true },
                y: {
                    stacked: true,
                    ticks: {
                        callback: value => `${value/1000}k`
                    }
                }
            },
            plugins: {
                tooltip: {
                    callbacks: {
                        label: function(context) {
                            return `${context.dataset.label}: ${formatCurrency(context.raw)}`;
                        }
                    }
                }
            }
        }
    });

    new Chart(document.getElementById('opexChart'), {
        type: 'doughnut',
        data: {
            labels: financialData.opexY1.labels,
            datasets: [{
                label: 'OPEX Ano 1',
                data: financialData.opexY1.data,
                backgroundColor: ['#1d4ed8', '#1e40af', '#1e3a8a', '#2563eb', '#3b82f6', '#60a5fa', '#93c5fd', '#bfdbfe'],
                hoverOffset: 4
            }]
        },
        options: {
            responsive: true,
            maintainAspectRatio: false,
            plugins: {
                legend: { position: 'bottom' },
                tooltip: {
                    callbacks: {
                        label: function(context) {
                            return `${context.label}: ${formatCurrency(context.raw)}`;
                        }
                    }
                }
            }
        }
    });

    const dsoSlider = document.getElementById('dsoSlider');
    const dpoSlider = document.getElementById('dpoSlider');
    const dsoValue = document.getElementById('dsoValue');
    const dpoValue = document.getElementById('dpoValue');
    const cashTroughResult = document.getElementById('cashTroughResult');

    function updateSensitivity() {
        const dso = dsoSlider.value;
        const dpo = dpoSlider.value;
        dsoValue.textContent = dso;
        dpoValue.textContent = dpo;
        const key = `DSO${dso}_DPO${dpo}`;
        const result = financialData.sensitivity[key];
        cashTroughResult.textContent = formatCurrency(result);
    }

    dsoSlider.addEventListener('input', updateSensitivity);
    dpoSlider.addEventListener('input', updateSensitivity);
    
    const sections = document.querySelectorAll('section');
    const navLinks = document.querySelectorAll('.nav-link');

    const observer = new IntersectionObserver((entries) => {
        entries.forEach(entry => {
            if (entry.isIntersecting) {
                navLinks.forEach(link => {
                    link.classList.toggle('active', link.getAttribute('href').substring(1) === entry.target.id);
                });
            }
        });
    }, { rootMargin: "-50% 0px -50% 0px" });

    sections.forEach(section => {
        observer.observe(section);
    });

    // Subpage script
    const initialApiData = {
        labels: ['China', 'India', 'Rest of World', 'EU'],
        datasets: [{
            label: 'Current API Sources',
            data: [40, 25, 25, 10],
            backgroundColor: ['#D68A7B', '#E5A99D', '#F0C7BE', '#F8E9E6'],
            borderColor: '#FFFFFF',
            borderWidth: 2
        }]
    };

    const targetApiData = {
        labels: ['China', 'India', 'Rest of World', 'EU'],
        datasets: [{
            label: 'Target API Sources',
            data: [20, 15, 35, 30],
            backgroundColor: ['#D68A7B', '#E5A99D', '#F0C7BE', '#9BB5A1'],
            borderColor: '#FFFFFF',
            borderWidth: 2
        }]
    };

    const apiCtx = document.getElementById('apiSourceChart').getContext('2d');
    const apiSourceChart = new Chart(apiCtx, {
        type: 'doughnut',
        data: initialApiData,
        options: {
            responsive: true,
            maintainAspectRatio: false,
            plugins: {
                legend: {
                    position: 'bottom',
                },
                title: {
                    display: true,
                    text: 'Current API Source Dependency (%)'
                }
            }
        }
    });

    const toggleBtn = document.getElementById('toggleApiSourceBtn');
    let isInitialData = true;
    toggleBtn.addEventListener('click', () => {
        isInitialData = !isInitialData;
        if (isInitialData) {
            apiSourceChart.data = initialApiData;
            apiSourceChart.options.plugins.title.text = 'Current API Source Dependency (%)';
            toggleBtn.textContent = 'Show Post-Act Target Scenario';
        } else {
            apiSourceChart.data = targetApiData;
            apiSourceChart.options.plugins.title.text = 'Post-Act Target Source Dependency (%)';
            toggleBtn.textContent = 'Show Current Scenario';
        }
        apiSourceChart.update();
    });

    const shortageCostCtx = document.getElementById('shortageCostChart').getContext('2d');
    new Chart(shortageCostCtx, {
        type: 'bar',
        data: {
            labels: ['Alternative Drugs', 'Admin Overhead', 'Longer Hospital Stays', 'Lab Tests'],
            datasets: [{
                label: 'Estimated Annual Cost (‚Ç¨ Billions)',
                data: [1.5, 0.9, 1.2, 0.4],
                backgroundColor: '#D68A7B',
                borderColor: '#C06C5B',
                borderWidth: 1
            }]
        },
        options: {
            responsive: true,
            maintainAspectRatio: false,
            indexAxis: 'y',
            plugins: {
                legend: {
                    display: false,
                },
                title: {
                    display: true,
                    text: 'Main Cost Drivers of Drug Shortages in EU'
                }
            },
            scales: {
                x: {
                    beginAtZero: true
                }
            }
        }
    });
    
    const flowSteps = document.querySelectorAll('.flow-step');
    const flowDetailsContainer = document.getElementById('flow-details');
    const flowDetailsContent = {
        'flow-1': {
            title: 'Opportunity at the Source (MAH)',
            text: 'Offer SaaS platforms for predictive analytics to forecast demand spikes and potential production delays. Provide consulting services to help MAHs set up robust internal monitoring systems that meet regulatory standards.'
        },
        'flow-2': {
            title: 'Opportunity at the National Level',
            text: 'Develop automated reporting tools that seamlessly translate company data into the format required by National Competent Authorities. Offer services to manage communication and follow-up during a shortage investigation.'
        },
        'flow-3': {
            title: 'Opportunity at the EU Level',
            text: 'Provide data aggregation and analysis services that help larger bodies or consortiums interpret EU-wide data. While direct interaction is limited, the need for high-quality data at steps 1 and 2 is driven by this final aggregation step.'
        }
    };
    
    flowSteps.forEach(step => {
        step.addEventListener('click', () => {
            flowSteps.forEach(s => s.classList.remove('active'));
            step.classList.add('active');
            const content = flowDetailsContent[step.id];
            flowDetailsContainer.innerHTML = `
                <h4 class="font-bold text-lg mb-2 text-[#383838]">${content.title}</h4>
                <p class="text-gray-600">${content.text}</p>
            `;
        });
    });

});
</script>
</body>
</html>

